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ABSTRACT The human fungal pathogen Candida albicans requires respiratory func-
tion for normal growth, morphogenesis, and virulence. Mitochondria therefore represent
an enticing target for the development of new antifungal strategies. This possibility is
bolstered by the presence of characteristics speciﬁc to fungi. However, respiration in C.
albicans, as in many fungal organisms, is facilitated by redundant electron transport
mechanisms, making direct inhibition a challenge. In addition, many chemicals known to
target the electron transport chain are highly toxic. Here we made use of chemicals with
low toxicity to efﬁciently inhibit respiration in C. albicans. We found that use of the nitric
oxide donor sodium nitroprusside (SNP) and of the alternative oxidase inhibitor salicyl-
hydroxamic acid (SHAM) prevents respiration and leads to a loss of viability and to cell
wall rearrangements that increase the rate of uptake by macrophages in vitro and in
vivo. We propose that treatment with SNP plus SHAM (SNPSHAM) leads to transcrip-
tional changes that drive cell wall rearrangement but which also prime cells to activate
the transition to hyphal growth. In line with this, we found that pretreatment of C. albi-
cans with SNPSHAM led to an increase in virulence. Our data reveal strong links be-
tween respiration, cell wall remodeling, and activation of virulence factors. Our ﬁndings
demonstrate that respiration in C. albicans can be efﬁciently inhibited with chemicals
that are not damaging to the mammalian host but that we need to develop a deeper
understanding of the roles of mitochondria in cellular signaling if they are to be devel-
oped successfully as a target for new antifungals.
IMPORTANCE Current approaches to tackling fungal infections are limited, and new
targets must be identiﬁed to protect against the emergence of resistant strains. We in-
vestigated the potential of targeting mitochondria, which are organelles required for en-
ergy production, growth, and virulence, in the human fungal pathogen Candida albicans.
Our ﬁndings suggest that mitochondria can be targeted using drugs that can be toler-
ated by humans and that this treatment enhances their recognition by immune cells.
However, release of C. albicans cells from respiratory inhibition appears to activate a
stress response that increases the levels of traits associated with virulence. Our results
make it clear that mitochondria represent a valid target for the development of antifun-
gal strategies but that we must determine the mechanisms by which they regulate
stress signaling and virulence ahead of successful therapeutic advance.
KEYWORDS Candida albicans, cell wall, mitochondria, mycology, yeast
C
andida albicans is one of the most prevalent fungal pathogens and a major cause
of nosocomial infections which have a high mortality rate (1). Current antifungals,
although effective, target a limited number of cellular processes, and the development
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of new therapeutic approaches is essential. C. albicans requires mitochondrial function
for normal growth, morphogenesis, and virulence (2–4), but mitochondria had not
been exploited as a therapeutic target to date. Given the central role of this organelle
in processes essential for growth, maintenance, and adaptability, coupled to the
presence of fungal speciﬁc characteristics, it may be possible to develop therapies
based on mitochondrial inhibition.
C. albicans is a Crabtree effect-negative yeast and relies mainly on oxidative phos-
phorylation for ATP production during growth and morphogenesis. It possesses a
classical electron transfer chain (ETC), consisting of complexes I to IV, as well as a
cyanide-insensitive alternative oxidase, which permits respiration when the classical
chain is inhibited (Fig. 1A) (5). A functional electron transport system has been shown
to be important for aspects of C. albicans biology that are linked to virulence. For
example, inhibition of respiration in C. albicans and other pathogenic fungi leads to a
decreased growth rate (6). Mutants defective in respiration have consistently been
shown to affect the hyphal morphological switch, an important determinant of viru-
lence in C. albicans, whether negatively (goa1Δ, ndh51Δ) (7) or positively (dbp4Δ, hfl1Δ,
rbf1Δ) (8). Respiratory inhibition has been linked to reduced activation of Ras1 signal-
ing, a major determinant of morphogenesis, via an uncharacterized mechanism that
correlates with reduced ATP levels (9). A link between electron transport and control of
Ras1 has also been suggested to regulate a loss of hyphal growth under anaerobic
conditions (10).
The cell wall is critical for viability of fungal pathogens and is a major determinant
of virulence. Its composition and organization also determine the recognition of C.
albicans by the immune system (11–13). Recent work has shown that masking of cell
wall components facilitates immune evasion. Changes in surface beta-glucan exposure
can occur in response to a variety of stimuli, including changes in carbon sources and
pH (14, 15). A number of studies have suggested that mitochondrial function may be
linked to the maintenance of the C. albicans cell wall. Loss of the complex I regulator
Goa1 revealed a link between respiration and sensitivity to cell wall-damaging agents
(16) and cell wall architecture (17). In addition, impairment of mitochondrial function by
deletion of SAM37, which encodes a component of the mitochondrial outer membrane
sorting and assembly machinery (SAM) complex, also resulted in defects in cell wall
integrity (CWI) (18). Mitochondrial interaction with the endoplasmic reticulum is also
important for maintaining cell wall integrity; deletion of the mitochondrial GTPase
Gem1 led to abnormal mitochondrial morphology and susceptibility to cell wall stress
through reduced Cek1 activation (19). A better understanding of the links between
mitochondrial function and virulence and, indeed, of the consequences of respiration
inhibition are crucial if we are to develop mitochondria as a potential drug target.
In an attempt to understand the consequences of respiration inhibition in C.
albicans, we adopted a pharmacological approach. We made use of nitric oxide (NO),
which inhibits respiration at the level of complex IV and has a safe record for use as a
vasodilator (20) and in dermatologic applications (21). NO has been evaluated as a
therapy in a variety of bacterial and fungal infections, including infections by Pseu-
domonas aeruginosa in cases of cystic ﬁbrosis and infections caused by dermatophytes
(22–24). NO inhibition of cytochrome c oxidase at low concentrations is rapidly revers-
ible by oxygen treatment. However, permanent inhibition of respiration can result at
higher NO concentrations (25). In addition, NO causes the formation of reactive
nitrogen species (such as peroxynitrite) which can damage mitochondrial function and
which have been shown to have strong antifungal activity (26). Several studies reported
the efﬁcacy of NO against C. albicans (27–29). The alternative oxidase can be inhibited
by hydroxamic acids such as salicylhydroxamic acid (SHAM). The low in vivo toxicity of
alternative oxidase inhibitors such as SHAM and ascofuranone has been evaluated with
respect to their ability to treat trypanosomiasis (30, 31).
We found that C. albicans cells are highly adaptive to classical respiration inhibition
but that a combination of SHAM and the NO donor sodium nitroprusside (SNP)
(SNPSHAM) led to ﬁtness defects and loss of viability. In addition, treatment with
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SNPSHAM led to cell wall organization defects that unmasked C. albicans cells and to
increased immune cell recognition in cell culture and animal models. However, release
of cells from SNPSHAM treatment led to a rapid activation of the hyphal transition
program and increased virulence in a mouse model. Our data suggest that mitochon-
dria form part of a complex response network that is imbedded within the cellular
responses required for C. albicans virulence.
RESULTS
SNPSHAM inhibits respiration and growth and reduces viability in C. albi-
cans. Our goal was to identify conditions that would allow the reproducible inhibition
FIG 1 SNPSHAM treatment inhibits respiration and reduces viability. (A) Schematic of electron transport pathways in C. albicans, representing complexes I
to IV of the classical pathway (red arrows), the alternative oxidase pathway (AOX) (blue arrows), and the parallel pathway (PAR) (not shown in detail) (green
arrows). Shown in italics are commonly used inhibitors. (B) A representative example of respiration in whole C. albicans cells determined using high-resolution
respirometry. SNP and SHAM were added where indicated, resulting in ﬁnal concentrations of 1 and 2 mM for both. Potassium cyanide (KCN) was added to
a ﬁnal concentration of 2 mM. (C) Respiration was inhibited by SNPSHAM or 2 mM KCN treatment, and the results were compared to those seen with
untreated controls (n  6). *, P  0.01. (D) Aox2 expression was monitored by immunoblotting following addition of 1 mM SNP in samples taken from aox2Δ
aox1Δ or control cells. (E) Growth was monitored over time in the presence of increasing concentrations of SNPSHAM. (F) Cells were grown in the presence
of 1 mM SNP–0.5 mM SHAM for 3 h and 18 h before viability was determined by CFU assay (n  4). Graphs show means  standard deviations. Student’s t test
was used to compare groups. *, P  0.01.
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of classical and alternative respiration in C. albicans. Complex I can be inhibited by
rotenone, complex III by antimycin A, and complex IV by cyanide (Fig. 1A). However,
although effective as research tools, these compounds are highly toxic and unsuitable
for use in humans. As an alternative to treatment with cyanide compounds, oxygen
consumption was measured upon exposure of cells to the nitric oxide donor SNP,
which inhibits cytochrome c oxidase, and to the alternative oxidase (Aox) inhibitor
SHAM. Initial titration experiments suggested that the concentrations of 1 mM SNP and
0.5 mM SHAM were suitable for our purpose. Recovery from NO-induced inhibition of
classical respiration by SNP addition was rapid, with full restoration achieved within 30
min (Fig. 1B). Further application of SNP did not lead to a reduction in oxygen
consumption, suggesting that cells had switched to alternative respiration upon SNP
treatment (Fig. 1B). This was conﬁrmed by subsequent addition of SHAM, which
decreased the respiration level signiﬁcantly (Fig. 1B). Addition of 2 mM cyanide was
sufﬁcient to inhibit the remaining respiration. Simultaneous addition of SNPSHAM led
to a signiﬁcant loss of respiration that was comparable to that observed upon cyanide
addition (Fig. 1C; see also Fig. S1A in the supplemental material). In support of the idea
of a rapid transition to alternative respiration, an increase in Aox2 protein levels was
detectable within 20 min following exposure to SNP (Fig. 1D). Addition of SHAM alone
did not lead to a decrease in respiration (Fig. S1B), suggesting that AOX did not
contribute signiﬁcantly except under conditions of induction in response to inhibition
of the classical respiratory chain.
Given the effects of SNPSHAM on respiration, we investigated its effects on growth
and viability. Incubation of C. albicans cells with SNPSHAM led to a decrease in
growth and in ﬁnal biomass in a dose-dependent manner (Fig. 1E). Treatment with
SNPSHAM for 3 h did not have a signiﬁcant effect on viability; however, prolonged
SNPSHAM exposure resulted in decreased viability compared to the results seen with
untreated controls (Fig. 1F). These data suggest that C. albicans possesses a robust and
adaptable respiratory system that can be targeted using a SNPSHAM cotreatment
approach.
SNPSHAM treatment induces structural rearrangements within the cell wall.
Previous studies suggested a link between respiration and cell wall integrity (8, 16). Our
goal was to determine whether chemical inhibition of respiration using SNPSHAM
could negatively impact cell wall integrity. In line with this, SNPSHAM exposure led
to a reduction in growth and to sensitivity to the cell wall-damaging agents calcoﬂuor
white (CFW) and Congo red (CR) at both 30 and 37°C (Fig. 2A). We employed trans-
mission electron microscopy to examine cell wall structure following SNPSHAM
treatment (Fig. 2B). This analysis revealed that the outer cell wall, composed of
mannans and cell wall proteins, but not the inner cell wall was reduced in thickness
compared to untreated cells (Fig. 2B and C). High-performance liquid chromatography
(HPLC) analysis of acid-hydrolyzed cell wall components showed that SNPSHAM
treatment caused no signiﬁcant changes in the relative levels of chitin, glucan, or
mannan (Fig. 2D). This suggests that cell wall changes induced by SNPSHAM may be
due to changes in organization rather than to gross changes in the relative levels of cell
wall components. Interestingly, we also observed the presence of a large structure
adjacent to the vacuole within SNPSHAM-treated cells (Fig. 2E). We conﬁrmed this to
be a lipid droplet by the use of the neutral lipid stain LD540 (Fig. 2F). SNP treatment
alone was sufﬁcient to induce lipid droplet accumulation, suggesting a link to inhibition
of classical respiration (Fig. 2F). This ﬁnding suggests a link between respiratory
inhibition and the regulation of lipid metabolism in C. albicans.
Caspofungin resistance reveals a link between respiration inhibition and Upc2.
Cell wall damage can be sensed and repaired by activation of the cell wall integrity
(CWI) pathway (32). To determine whether this mechanism was engaged by
SNPSHAM treatment, CWI pathway activity was measured by detection of the phos-
phorylated forms of Mkc1, a well-characterized marker of pathway activation (33). We
also determined whether SNPSHAM treatment led to the activation of Hog1, a major
oxidative stress response regulator that also inﬂuences cell wall biosynthesis (34).
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Unlike the results seen with the positive controls, SNPSHAM treatment did not cause
activation of Hog1 or Mkc1 (Fig. 3A). This suggests either that the major cell wall
integrity responses are not involved in SNPSHAM-induced cell wall changes or that
the mitochondrial compartment functions downstream of Hog1 and Mkc1 within the
cell wall response.
To identify potential regulators of the SNPSHAM response that may be important
in cell wall organization, we treated C. albicans with a combination of SNPSHAM and
FIG 2 SNPSHAM treatment leads to cell wall alterations and altered lipid metabolism. (A) Wild-type cells were serially diluted
(1:10 dilutions), and equal volumes were spotted onto YPD plates (at 30 or 37°C) containing 1 mM SNP–0.5 mM SHAM and
25 g/ml calcoﬂuor white (CFW) or 40 g/ml Congo red (CR). (B) Cells were treated with 1 mM SNP–0.5 mM SHAM for 18 h
and processed for transmission electron microscopy (TEM). Representative examples of untreated and SNPSHAM-treated
cells are shown. Bar  100 nm. (C) Quantiﬁcation of outer cell wall (o) and inner cell wall (i) thicknesses was carried out from
TEM images. Measurements were taken at 5 points along the cell wall for 25 cells per group. Bar  100 nm. (D) Cell wall
material was extracted and acid hydrolyzed from cells treated with 1 mM SNP–0.5 mM SHAM for 18 h, followed by HPLC
analysis (n  3). Graphs show means  standard deviations. (E) TEM images from cells treated with SNPSHAM. Arrows
indicate lipid droplets. Bar  500 nm. (F) Control and SNP-, SHAM-, or SNPSHAM-treated cells were stained using LD540
neutral lipid stain and viewed by ﬂuorescence microscopy. Bar  10 m. Student’s t test was used to compare groups. *,
P  0.01.
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caspofungin, which targets the cell wall (Fig. 3B). We observed that SNPSHAM
treatment led to caspofungin resistance, presumably as a result of the alteration in cell
wall structure (Fig. 3B). Using this phenotype, we screened a library of transcription
factor deletion mutants (35) by growing the strains in the presence of SNPSHAM in
combination with caspofungin at a level that inhibited growth of the wild-type (WT)
strain. A single transcription factor, Upc2, was found to be required for caspofungin
resistance upon SNPSHAM treatment. Deletion of UPC2, which plays an important
role in the regulation of ergosterol biosynthesis (36), led to a reproducible reduction in
caspofungin resistance upon exposure to cotreatment with SNPSHAM (Fig. 3C). To
conﬁrm the results from the initial screen, microdilution growth assays of caspofungin
in combination with SNPSHAM were performed. An independently derived upc2Δ
mutant (37) showed a caspofungin MIC that was 8-fold lower that than seen with the
wild-type strain when SNPSHAM were added in combination (Fig. 3D). These data
suggests a role for Upc2 in regulating cell wall changes in response to SNPSHAM
treatment.
FIG 3 SNPSHAM-induced cell wall changes do not induce Mkc1 or Hog1 activation but alter caspofungin sensitivity, which requires
Upc2. (A) Cells were treated with 1 mM SNP–0.5 mM SHAM (SS) for 1 h or 18 h. Activation of Mkc1 was determined using p44/42 antibody.
Cells treated with 25 g/ml calcoﬂuor white (CFW) were used as a positive control. Activation of Hog1 was determined using p38 antibody,
with cells treated with 2 mM hydrogen peroxide used as a positive control. The level of anti-actin on the respective blots is shown as a
loading control. (B) Wild-type cells were grown with 1 mM SNP–0.5 mM SHAM and/or 100 ng/ml caspofungin (n  3). (C) The upc2Δ
mutant and the corresponding wild-type strain were grown in synthetic complete medium with 1 mM SNP–0.5 SHAM or in combination
with 100 ng/ml caspofungin. A representative data set is displayed (n  3). (D) Microdilution assays were performed with 3.9 ng/ml to
8 g/ml caspofungin with or without 1 mM SNP–0.5 mM SHAM. The table shows the MICs for caspofungin for the wild-type strain and
the upc2Δ mutant with or without SNPSHAM (n  3).
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Analysis of transcriptional changes in response to SNPSHAM treatment. To
further investigate the changes caused by SNPSHAM, we examined the transcrip-
tional response of C. albicans to this treatment using RNA sequencing. RNA was
extracted from log-phase yeast cells exposed to 1 mM SNP or 0.5 mM SHAM or both for
30 min (Fig. 4; see also Tables S2, S3, and S4 in the supplemental material). A short
exposure time was selected in order to capture early alterations rather than proﬁles
FIG 4 Transcriptome of wild-type C. albicans treated with SNP, SHAM, or SNPSHAM. (A) Venn diagram showing overlap in differentially
expressed genes between SNP, SHAM, and SNPSHAM treatments by RNA-seq analysis as described in Materials and Methods. PE, phosphati-
dylethanolamine. (B) A selection of differentially expressed genes in SNPSHAM-treated cells were grouped by GO term, with log2 fold change
versus untreated shown. Green indicates downregulated genes, and red/yellow indicates upregulated genes. Differentially expressed genes were
identiﬁed by Cuffdiff v2.1.1, with false-discovery-rate (q) values of 0.05 being considered statistically signiﬁcant.
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from the expansion of adapted cell lineages. SNP and SNPSHAM treatment led to
differential expression of over 1,500 genes, whereas SHAM treatment led to a smaller
range of responses, with only 131 genes differentially expressed (Fig. 4A; see also Tables
S2, S3, and S4). A signiﬁcant overlap of differentially expressed genes within the SNP
and SNPSHAM treatment data sets was observed (Fig. 4A). As expected, the AOX2 and
AOX1 genes encoding the alternative oxidases and genes required for a response to
nitric oxide, such as YHB1, were upregulated in both the SNP-only group and the
SNPSHAM group. Several genes encoding components of classical respiration were
downregulated upon SNP SHAM treatment, whereas genes involved in the glyoxylate
cycle (MLS1 and ICL1) and glycolysis and gluconeogenesis (FBP1, GPM1, GPM2, PCK1,
PGI1, PGK1) (Tables S2 and S4) were upregulated. These changes suggest a shift in
carbon metabolism in response to respiration inhibition.
A number of transcriptional regulators were upregulated in response to both
classical and alternative respiration inhibition (Fig. 4A). To examine which key regula-
tors were involved in the response to SNPSHAM treatment, we analyzed the genes on
the list of those differentially expressed using PathoYeastract, a tool which ranks
transcription factors in the order of the number of genes in the list that they regulate
and for which there exists supporting expression evidence (38). This analysis showed
that the Sko1 transcription factor has regulatory associations with 33.8% of the differ-
entially expressed genes. SKO1 itself was upregulated upon SNPSHAM treatment.
Interestingly, the upregulation of SKO1 seems to have been a SHAM-speciﬁc effect, as
it was not differentially expressed in the SNP-only data set. Upc2 binding sites were
identiﬁed within the promoters of 13.4% of the genes differentially regulated upon
SNPSHAM treatment. This, along with the fact that UPC2 expression was itself
upregulated upon SNPSHAM treatment, further suggests a role for this transcription
factor.
Analysis of SNPSHAM RNA-seq data showed that several genes involved in chitin
synthesis and organization were downregulated, including the CHT1, CHT2, and CHT4
chitinase genes (Fig. 4B). Mannan biosynthesis and organization genes were upregu-
lated, as were genes involved in -glucan synthesis and organization. However, as no
signiﬁcant changes in relative glucan, mannan, or chitin levels were detected by HPLC,
these changes do not seem to be realized at the protein level. One possibility is that
SNPSHAM-induced transcriptional changes led to alterations in cell wall organization
but not to substantial changes in composition. Supporting this hypothesis, we ob-
served that several glycosylphosphatidylinositol (GPI)-anchored cell wall protein genes
that play a role in cross-linking cell wall components were also differentially expressed
(Fig. 4B).
Genes encoding chitinase Cht2 and GPI-anchored cell wall protein Pga26, previously
shown to have roles in the unmasking of cell wall -glucan, were downregulated (15).
This appears to have been a result of inhibition of classical respiration, as SNP treatment
alone led to reduced expression of CHT2 and PGA26. The majority of genes in the
so-called “common in fungal extracellular membranes” (CFEM) family, including PGA7,
PGA10, RBT5, and CSA2, were upregulated (39). These genes encode proteins with roles
in iron acquisition and adhesion. Expression of several of these genes is controlled by
Bcr1, a transcription factor known to be important in the hypoxic response (40), and
BCR1 was itself upregulated. Genes involved in adhesion, including several of the ALS
genes, as well as the RIM101 regulator were also upregulated (Fig. 4B).
SNPSHAM treatment also led to changes in genes involved in lipid metabolism.
Upregulation of several lipase genes suggested a mobilization of lipid stores (see
Table S4). This is in agreement with our observation of increased formation of lipid
droplets upon SNPSHAM treatment (Fig. 2E and F). A number of genes involved in the
ergosterol biosynthesis pathway were downregulated (Fig. 4B). In addition, genes
involved in the synthesis of phosphatidylserine (PS) and phosphatidylcholine (PC)
(CHO1 and CHO2, respectively) and linoleic acid (FAD3 and FAD2) were also downregu-
lated. Collectively, these data suggest that SNPSHAM treatment led to changes in
lipid metabolism.
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SNPSHAM treatment increased surface chitin and -glucan exposure. Our
data suggests that inhibition of respiration led to cell wall rearrangement (Fig. 2B to D).
To investigate this further, we assessed the exposure of chitin and -glucan at the cell
surface using ﬂuorescent probes. Wheat germ agglutinin (WGA) binds chitin in fungal
cell walls but, due to its large size, cannot penetrate the cell wall to stain chitin in the
innermost layers where it is usually found (41). WGA therefore typically stains structures
such as bud scars where chitin is exposed, and staining of the lateral cell wall indicates
that chitin is exposed at the surface of the cell wall. SNPSHAM-treated cells exhibited
greater lateral wall staining than untreated cells (Fig. 5A and B). An increase in chitin
exposure was observed upon SNP treatment alone and was enhanced at 37°C com-
pared to 30°C (Fig. 5B). These results suggest that SNPSHAM treatment caused
exposure of the normally hidden chitin in the cell wall but that this effect was linked
to the effects of NO upon the classical respiratory chain. This effect was also previously
observed in a cek1Δ mutant (42), suggesting that SNPSHAM-induced chitin unmask-
ing is independent of Cek1 signaling (Fig. 5F).
FIG 5 SNPSHAM treatment induces surface exposure of chitin and (1,3)-glucan. (A) Representative examples of untreated cells and cells
treated with 1 mM SNP–0.5 mM SHAM for 18 h, stained with ﬂuorescein isothiocyanate (FITC)-wheat germ agglutinin (WGA), and analyzed using
ﬂuorescence microscopy. (B) Cells treated with SNP, SHAM, or SNPSHAM at 30 or 37°C were quantiﬁed for FITC-WGA staining as described in
Materials and Methods (n  3). (C) Representative examples of untreated and SNPSHAM-treated cells stained with dectin-1. Bar  10 m. (D)
Cells were quantiﬁed as described in Materials and Methods (n  3). AU, arbitrary units. (E and F) Effect of SNPSHAM treatment on chitin
unmasking as determined by WGA staining in upc2Δ and sko1Δ mutants (E) and in (F) cek1Δ mutants. Graphs show means  standard deviations.
At least three independent experiments were performed for each analysis. Student’s t test was used to compare groups. *, P  0.001.
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Dectin-1 recognizes (1,3)-glucan in the inner fungal cell wall and is one of the
major receptors involved in the immune response to fungal pathogens (43). To
determine whether SNPSHAM treatment causes a change in (1,3)-glucan exposure
in C. albicans, a soluble form of dectin-1 was used to stain treated cells. SNPSHAM
pretreatment signiﬁcantly increased the level of dectin-1 staining of the cell wall
(Fig. 5C and D). This suggests that the cell wall changes induced by SNPSHAM
treatment resulted in cell wall rearrangements exposing -glucan at the cell surface.
The observed sensitivity of upc2Δ cells to caspofungin in the presence of
SNPSHAM suggested that Upc2 links respiration to cell wall integrity. This led us to
examine the effect of SNPSHAM on chitin and -glucan exposure in the upc2Δ
mutant to determine whether Upc2 inﬂuences unmasking. The degree of surface chitin
exposure in upc2Δ and the increase in unmasking upon SNPSHAM treatment were
not signiﬁcantly different from levels seen with the wild type (Fig. 5E). Similarly, the
results of dectin-1 staining for upc2Δ were also not signiﬁcantly different from results
seen with the wild-type strain (Fig. S1C). These results suggest that cell wall unmasking
and the sensitivity to caspofungin in response to SNPSHAM treatment may not share
a mechanism.
Given that Upc2 was not linked to (1,3)-glucan or chitin exposure, we tested a
number of strains deleted for transcription factors that were identiﬁed as upregulated
within our RNA-seq data in response to SNPSHAM treatment. Our investigations did
not identify deletions of any single transcription factor that could prevent (1,3)-glucan
or chitin exposure. However, deletion of SKO1 led to an increase in chitin unmasking
following SNPSHAM exposure relative to the level seen with the wild-type strain
(Fig. 5E). This may suggest that Sko1 acts as a repressor of chitin unmasking or simply
that it is involved in the repair of cell wall rearrangements caused by this treatment.
We wished to examine whether other forms of respiration deﬁciency could lead to
the same cell wall unmasking phenotype. The ndh51Δ mutant (7) does not possess a
functional complex I and has a low respiration level. It showed a very high degree of
chitin unmasking as determined by WGA staining (Fig. S2A). Dectin-1 staining was also
signiﬁcantly increased, although to a lesser degree than in SNPSHAM-treated cells
(Fig. S2B). These results demonstrate that inhibition of the classical electron transfer
chain through the activity of either complex I or complex IV can cause unmasking of
chitin and (1,3)-glucan.
Pretreatment with SNPSHAM increased phagocytosis by macrophages. Due
to the higher (1,3)-glucan surface exposure in SNPSHAM-treated cells, it was hy-
pothesized that these cells may be recognized and engulfed more readily by macro-
phages. SNPSHAM-treated cells were coincubated with J774.1 murine macrophages
and were examined after 1 h by microscopy and scored for uptake. A higher proportion
of the SNPSHAM-pretreated cells than of untreated cells were taken up by macro-
phages after 1 h (Fig. 6A and B). In line with unmasking being linked to inhibition of
classical respiration, uptake by macrophages was enhanced to the same degree upon
SNP pretreatment (Fig. 6B). A similar increase in uptake was observed when cells were
pretreated with 1 mM potassium cyanide (KCN) only (Fig. S3A), also suggesting that
inhibition of the classical respiratory chain was responsible for this phenotype. In
agreement with this, inhibition of the alternative respiration pathway alone by the use
of SHAM or of the aox2Δ aox1Δ mutant had no signiﬁcant effect on uptake (Fig. S3A).
An increase in uptake of ndh51Δ cells was also observed, but the degree of increase was
not the same as that seen with SNPSHAM-pretreated cells (Fig. S3B). In order to
understand how SNPSHAM pretreatment would inﬂuence systemic candidiasis in vivo
during infection, we used the zebraﬁsh larva model, in which we could examine
phagocytosis of C. albicans in vivo. C. albicans expressing green ﬂuorescent protein
(GFP) was pretreated with SNPSHAM for 18 h. The pretreated cells were then injected
into zebraﬁsh larvae with ﬂuorescently labeled macrophages. Z-stack images of each
ﬁsh were taken using confocal microscopy, and uptake by macrophages was assessed
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manually. The uptake of pretreated cells was approximately 10% higher than the
uptake of untreated cells (Fig. 6C and D).
SNPSHAM pretreatment increased the virulence of C. albicans in a mouse
systemic model of candidiasis. It was not clear whether the increased uptake of
SNPSHAM-pretreated C. albicans by macrophages would attenuate virulence in vivo.
To determine this, C. albicans were pretreated with SNPSHAM before being washed
and injected into the tail vein of 6-to-8-week-old female BALB/c mice, and the pro-
gression of infection was followed by monitoring weight loss and the condition of the
animals. Kidney fungal burden measurements were made at 3 days postinfection to
give an “outcome score.” A higher outcome score is indicative of greater weight loss
and higher fungal burdens and thus of virulence. It was observed that the weight loss
caused by SNPSHAM-pretreated C. albicans was more rapid than that seen with the
controls (Fig. 7A). Infection with SNPSHAM-treated C. albicans cells also led to
signiﬁcantly higher fungal burdens within the kidney at the time of culling. The
combination of these factors led to a signiﬁcantly higher outcome score for
SNPSHAM-pretreated cells than for untreated cells (Fig. 7A). Histological analysis of
kidney tissue from mice infected with cells pretreated with SNP-SHAM revealed an
increase in immune inﬁltrate and fungal cell numbers compared to controls (Fig. 7B).
FIG 6 C. albicans pretreated with SNPSHAM showed increased uptake by murine macrophages and by zebraﬁsh macrophages in vivo. (A)
Wild-type cells were treated with 1 mM SNP–0.5 mM SHAM for 18 h and then washed in phosphate-buffered saline (PBS) and coincubated with
J774.1 murine macrophages (3:1 C. albicans/macrophage ratio). Representative examples of uptake after 1 h coincubation are shown. (B) Uptake
of cells treated with SNP, SHAM, or SNPSHAM was quantiﬁed by counting at least 200 C. albicans cells per experiment. *, P  0.001. Five
independent experiments were carried out. The percentage of uptake was determined as the number of internalized C. albicans cells relative to
the total number of C. albicans cells. (C) Wild-type GFP-labeled C. albicans cells were treated with 1 mM SNP–0.5 mM SHAM for 18 h, washed, and
injected into zebraﬁsh larvae. A representative microscopy image of C. albicans (green) being taken up by macrophages (red) in vivo is presented
(1, phagocytosed C. albicans; 2, single C. albicans cell; 3, single macrophage). (D) Proportions of phagocytosed C. albicans cells were calculated
from images taken from three independent experiments (n  3). *, P  0.01. Graphs show means  standard deviations. Student’s t test was used
to compare groups.
Respiration Inhibition in Candida albicans ®
January/February 2019 Volume 10 Issue 1 e02535-18 mbio.asm.org 11
 o
n
 M
arch 8, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
FIG 7 Pretreatment of C. albicans increases virulence in the mouse model and leads to more-rapid ﬁlamentation. (A) C. albicans cells were
treated with SNPSHAM for 18 h and then washed in PBS prior to injection via the tail vein. Weight loss, fungal burden, and outcome score
were calculated as described in Materials and Methods. *, P  0.05. (B) Cross-section from kidney infected with untreated wild-type or
SNPSHAM-pretreated cells, both stained with hematoxylin and eosin (Hem  Eos; bar, 50 m) to emphasize locations of immune inﬁltration
(white arrows) or periodic acid-Schiff reagent (PAS; bar, 20 m) to highlight C. albicans cells (black arrows). (C) Wild-type cells were treated
with 1 mM SNP–0.5 mM SHAM for 18 h and then washed in PBS and transferred to serum-containing medium at 37°C. Representative
examples of ﬁlamentation in wild-type untreated and SNPSHAM-pretreated cells after 90 min. (D) The percentages of ﬁlamentous cells were
calculated in cells pretreated with SNP, SHAM, or SNPSHAM, washed, and grown for 90 min as described for panel C (n  3). (E) Wild-type
and aox2Δ aox1Δ mutant cells were treated with 1 mM SNP–0.5 mM SHAM for 18 h and then washed in PBS and transferred to
serum-containing medium at 37°C for 90 min before assessment. Graphs show means  standard deviations. Three independent experiments
were performed for each analysis. Student’s t test was used to compare groups. *, P  0.01.
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The resulting data suggest that pretreatment with SNPSHAM did not reduce the
ﬁtness of C. albicans in the host but in fact increased virulence in the murine model.
One possibility is that pretreatment of C. albicans with SNPSHAM may cause a
stress response which primes cells to activate traits associated with virulence when the
pretreated C. albicans is injected into the host. The rapid induction of ﬁlamentation is
generally associated with increased escape from macrophages and virulence (44, 45).
To investigate this, the incidence of hyphal formation was assessed after 90 min of
incubation in serum-containing media at 37°C for cells which had been pretreated with
SNPSHAM for 18 h. The majority of pretreated cells showed ﬁlamentation within
90 min, while the untreated cells were slower to transition to hyphae under these
conditions (Fig. 7C and D). The activation of rapid ﬁlamentation was also observed
when cells were treated with SNP alone but was not seen with SHAM-only treatment
(Fig. 7D). These results suggest that respiratory inhibition may prime cells for hyphal
growth and that this facilitates a rapid hyphal switch when the inhibitors are removed.
In agreement with this, a similar effect was observed when cells were pretreated with
cyanide (Fig. S4A and S4B in the supplemental material). Since both cyanide and NO
induce alternative respiration, germination after SNPSHAM treatment was examined
in an aox2Δ aox1Δ mutant. The mutant did not show the same level of hyphal
formation as the WT, suggesting that the alternative oxidase enzymes are required for
the ﬁlamentation response upon inhibition of classical respiration (Fig. 7E). It is possible
that the inhibition of the respiratory chain could lead to increased reactive oxygen
species (ROS) production and that this might provide a signal that promotes hyphal
switching. To investigate this, we assessed superoxide production and found that an
increase could be detected upon SNPSHAM treatment (Fig. S4C). The addition of
N-acetyl cysteine was sufﬁcient to prevent ROS accumulation but did not prevent the
activation of ﬁlamentation in SNPSHAM-treated cells (Fig. S4C and D). These data do
not support the idea of a role for ROS production in linking the inhibition of respiration
to ﬁlamentation.
DISCUSSION
Mitochondrial function has been studied extensively in the model yeast Saccharo-
myces cerevisiae but has been a neglected area in the study of pathogenic fungi.
Mitochondria have essential roles in pathogenicity (46) and antifungal drug resistance
(3). The electron transport chain of C. albicans, consists of an alternative and parallel
pathway in addition to the classical ETC (47); this allows electron ﬂow to be rerouted
should one of the pathways become blocked. Nevertheless, simultaneous inhibition of
the classical and alternative pathways can inhibit respiration by up to 90% and severely
restricts growth (48).
We have shown that NO exposure resulting from SNP treatment is effective in
inhibiting respiration and activation of an alternative respiration response, as has been
shown for other inhibitors of classical respiration (48). Inhibition of both classical and
alternative respiration using SNPSHAM led to sustained inhibition of respiration,
suggesting that the level of NO released by SNP in our experiments was sufﬁcient to
irreversibly inhibit cytochrome c oxidase. Peroxynitrite, which can be formed when NO
reacts with endogenous superoxide, has also been shown to cause irreversible inhibi-
tion of cytochrome c oxidase (49).
SNPSHAM treatment showed a synergistic effect with cell wall-damaging agents,
calcoﬂuor white, and Congo red. C. albicans respiration-deﬁcient mutants dpb4Δ, hfl1Δ,
and rbf1Δ (8) and mutants goa1Δ and ndh51Δ (16) have similarly been shown to be
sensitive to CFW and CR. A number of genes found to be differentially expressed upon
SNPSHAM treatment have been reported to be involved in the response to caspo-
fungin. Genes induced in this response include AGP2, KRE1, PGA13, RHR2, and CZF1;
repressed genes include CHT2, PGA4 and SCW11, HAS1, CRZ1, and ENG1 (50–52). These
expression changes may help to explain why SNPSHAM-treated cells were more
resistant to caspofungin.
Growth in the presence of SNPSHAM caused an increase in the surface exposure
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of chitin and (1,3)-glucan. Sherrington et al. showed that unmasking of (1,3)-glucan
and chitin occurred during adaptation to low pH (15).Those authors found no activation
of Mkc1 kinase involved in the cell wall integrity response and reported increased
uptake by macrophages, both of which were also seen in SNPSHAM-induced un-
masking. Masking of (1,3)-glucan has been shown to occur during growth on lactate,
which aids in immune evasion. (14). It was found that Crz1 was required for (1,3)-
glucan masking and that pga26Δ and cht2Δ mutants showed elevated (1,3)-glucan
exposure. These and other genes encoding cell wall proteins were found to be
downregulated in SNPSHAM-treated cells, suggesting repression of glucan masking
at the level of Crz1 but also a shift in the cell wall protein proﬁle, promoting elevated
(1,3)-glucan exposure (Fig. 4B).
The role of mitochondria in maintaining phospholipid homeostasis was previously
shown to be important for cell wall integrity (53). Genes involved in the synthesis of
phosphatidylserine (PS) (CHO1) and linoleic acid (FAD3 and FAD2) were also downregu-
lated in SNPSHAM-treated cells. The cho1Δ mutant, which is defective in PS synthesis,
was shown to exhibit unmasking of (1,3)-glucan (54), and CHO1 is also essential for cell
wall integrity (55). Treatment of cells with SNPSHAM also led to the downregulation
of a group of ergosterol biosynthesis pathway genes (Fig. 4B). Inhibition of sterol
biosynthesis has been shown to lead to an increase in the incidence of lipid droplets
(56), which we observed in SNPSHAM-treated cells. UPC2, encoding a transcription
factor known to activate ergosterol biosynthesis, especially under hypoxic conditions,
was upregulated and required for the observed resistance to caspofungin. Decreased
ergosterol production has previously been observed in respiration-deﬁcient C. albicans
mutants (57–59). An increase in UPC2 expression might be a compensatory response to
reduced ergosterol production, or, alternatively, SNPSHAM treatment might mimic
hypoxia, a condition that also leads to elevated Upc2 levels. In agreement with this, we
observed a signiﬁcant overlap in differential expression of genes with SNPSHAM
treatment and published microarray data produced under conditions of hypoxia (see
Fig. S5 in the supplemental material) (60). However, two recent studies clearly indicated
that hypoxic conditions led to alterations in the cell wall that mask C. albicans from host
responses (61, 62). This suggests that respiration inhibition and hypoxia lead to changes
in cell wall architecture via independent mechanisms. Shorter outer cell wall ﬁbrils were
seen in the respiration-deﬁcient goa1Δ mutant, similarly to those observed in
SNPSHAM-treated cells. The cell wall alterations in the goa1Δ mutant included a
reduction in the levels of high- and intermediate-molecular weight mannans (17), but
no signiﬁcant changes in the relative levels of glucan, chitin, or mannan were observed
in SNPSHAM-treated cells. In addition, the reduced recognition of the goa1Δ mutant
by macrophages, which contrasts with the results seen in SNPSHAM-treated cells,
suggested that the cell wall changes resulting from transient respiration inhibition were
distinct from those seen in the goa1Δ mutant.
Despite unmasking leading to an increase in immune cell recognition, SNPSHAM
pretreatment led to enhanced virulence in a mouse model, with a clear increase in
immune cell inﬁltrate and yeast cell numbers within the kidney (Fig. 7B). Exposure of
cell wall -glucan has been shown to increase the inﬂammation response (63). One
possibility, therefore, is that SNPSHAM pretreatment may have led to an increased
and damaging inﬂammation response. Another possibility rests with the activation of
hyphal switching that we observed upon removal of SNPSHAM. Enhanced germina-
tion may have facilitated escape from macrophages as well as damage to epithelial
barriers, aiding dissemination of the infection. It might have been the case that release
from respiratory inhibition (as the SNPSHAM-treated cells were washed prior to
injection) led to an increase in activation of Ras1, a key regulator of hyphal transition.
This hypothesis is supported by observations revealing that inhibition of respiration
decreases Ras1 activation, which prevents hyphal switching (9). Reduced Ras1 activity
in response to inhibition of respiration is correlated with a reduction in ATP levels; this
did not appear to be sensed by AMPK (9). The mechanism connecting mitochondrial
inhibition and Ras1 activation is unknown. The absence of an increase in hyphal
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switching in SNPSHAM-pretreated aox2Δ aox1Δ mutant cells suggests that an in-
creased level of Aox2 could be important for the increased switch to hyphae in
response to respiratory stress. This observation, together with previous evidence that
the alternative pathway is more active in hyphal cells (64), warrants further investiga-
tion into the precise role of Aox2 in morphogenetic switching.
In addition to hyphal growth regulators, several other virulence-related genes were
upregulated by SNPSHAM treatment. For example, Tsa1 (thioredoxin peroxidase 1),
which provides resistance to reactive nitrogen species and has also been shown to
contribute to fungal virulence (65), was among the most highly upregulated genes
following SNPSHAM treatment. Other upregulated genes associated with pathogen-
esis included SAP6 (66), GLK1 and PHO112 (67), and PLB1 (68) and the transcription
factor GAT1 as well as its regulation targets DUR1,2 and MEP2 (69). The induction of
these genes, several of which are normally associated with the hyphal form of C.
albicans, suggests that SNPSHAM treatment may prime cells for increased virulence,
which could manifest upon withdrawal of the treatment.
In summary, our study results suggest that inhibition of respiration as an antifungal
strategy in C. albicans is a complex proposition. Respiration inhibition with SNPSHAM
causes cell wall unmasking, which leads to enhanced recognition by macrophage cells
but primes a stress response leading to enhanced ﬁlamentation and increased viru-
lence when inhibition is removed. We would argue that the development of a mito-
chondrial inhibition strategy, while still an attractive goal given the importance of the
organelle for C. albicans growth, requires a better understanding of the signaling
properties of this organelle under conditions of stress.
MATERIALS AND METHODS
A detailed description of the strains and of the materials and methods used in this study can be
found in Text S1 in the supplemental material.
C. albicans growth conditions and chemicals. The C. albicans strains used in this study are
identiﬁed in Table S1 in the supplemental material. Growth and manipulation conditions are detailed
within Text S1. The aox2Δ aox1Δ and aox2Δ mutant strains used were constructed as detailed within
Text S1.
Whole-cell respirometry. Respirometry was carried out in real time using an Oxygraph-2k respi-
rometer (Oroboros Instruments, Austria) as detailed in Text S1. Data were analyzed using Datlab 6
software (Oroboros Instruments). Six independent experiments were performed.
Viability and susceptibility assays. Analysis of viability and sensitivity to cell wall-disrupting agents
or antifungal drugs was carried out as described in Text S1. In all cases, three independent experiments
were performed.
RNA isolation and RNA-seq. C. albicans SC5314 was grown for 5 h in yeast extract-peptone-dextrose
(YPD) at 30°C in a shaking incubator. SNP and SHAM were added to reach ﬁnal concentrations of 1 mM
and 0.5 mM, respectively, and the cells were returned to the incubator for a further 30 min. RNA was then
extracted and prepared for RNA sequencing as described in Text S1. Raw RNA-seq data were analyzed
using the suite of tools available on the Galaxy platform; for full details, see Text S1.
Cell wall staining and analysis. Cells from an overnight culture in YPD were diluted in YPD to a ﬁnal
optical density at 600 nm (OD600) of 0.2 and grown for 5 h at 30°C. SNP (1 mM) and SHAM (0.5 mM) were
added to the cultures, and they were grown for a further 18 h. The cells were processed for wheat germ
agglutinin or dectin-1 staining as described in Text S1. At least 400 cells were counted for each
experiment, and three independent experiments were performed per analysis. Cell wall composition was
analyzed by high-performance anion-exchange chromatography as described in Text S1.
Western blotting. Western blotting was carried out as described in Text S1. Phosphorylated Hog1
or Mkc1 was detected using p44/p42 (1:2,000) or p38 (1:1,000) monoclonal antibodies (Cell Signaling
Technology catalog no. 4695 and 8690, respectively). A monoclonal antibody (AS10 699, Agrisera,
Sweden) (1:100) against Sauromatum guttatum Aox which recognizes C. albicans Aox2 was used for Aox
immunoblotting. Actin was detected using an antibody raised against S. cerevisiae actin (a kind gift from
John Cooper, University of Washington) at a 1:1,000 dilution.
Phagocytosis assay. Uptake of C. albicans by J774.1 murine macrophages was carried out as
described in Text S1. The percentage of uptake was determined as the number of internalized C. albicans
cells relative to the total number of C. albicans cells. At least 200 C. albicans cells were counted for each
experiment. Five independent experiments were performed.
Hyphal induction. C. albicans hyphal induction assays were carried out as described in Text S1. The
percentage of hyphal cells was determined manually using ImageJ. A total of least 500 cells were
counted for each experiment.
Zebrafish in vivo imaging. Imaging of C. albicans uptake within 2-day-old zebraﬁsh was carried out
as described in Text S1. Assessment of C. albicans uptake by macrophages was performed manually using
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NIS-Elements Viewer 4.20 (Nikon, Richmond, United Kingdom). Three independent experiments were
performed using 10 larvae per condition.
Electron microscopy. Imaging of C. albicans sections by transmission electron microscopy was
carried out as described in Text S1. ImageJ was used to manually measure the thicknesses of the inner
(i) and outer (o) cell walls (as indicated in Fig. 2B). Five measurements were taken along the cell wall for
each cell, for a total of 25 cells per group.
Lipid droplet staining. LD540 lipid droplet stain was used as described in Text S1.
Murine C. albicans systemic infection model. The effect of SHAMSNP pretreatment of C. albicans
was evaluated using a murine intravenous challenge assay as described in the supplemental materials.
Mouse kidneys were cryosectioned and analyzed as described in Text S1.
Data accessibility. The data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO Series accession number GSE114531 (https://www
.ncbi.nlm.nih.gov/geo/query/acc.cgi?accGSE114531).
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